133 related articles for article (PubMed ID: 10777150)
1. False positivity of enzyme-linked immunosorbent assay for measurement of secretory IgA antibodies directed at HIV type 1 antigens.
Jackson S; Prince S; Kulhavy R; Mestecky J
AIDS Res Hum Retroviruses; 2000 Apr; 16(6):595-602. PubMed ID: 10777150
[TBL] [Abstract][Full Text] [Related]
2. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.
Black KP; Fultz PN; Girard M; Jackson S
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1273-82. PubMed ID: 9339844
[TBL] [Abstract][Full Text] [Related]
3. IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.
Black KP; Fultz PN; Girard M; Jackson S
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1263-72. PubMed ID: 9339843
[TBL] [Abstract][Full Text] [Related]
4. IgA testing for diagnosis of retroviral infections in the Caribbean.
Ridel PR; Artus JC; Capron A
Bull Pan Am Health Organ; 1991; 25(3):201-6. PubMed ID: 1742565
[TBL] [Abstract][Full Text] [Related]
5. Detection of HIV-Gag p24-specific antibodies in sera and saliva of HIV-1-infected adults and in sera of infants born to HIV-1-infected mothers.
Yasuda S; Iwasaki M; Oka S; Naganawa S; Nakasone T; Honda M; Sata T; Kojima A; Matsuda S; Takemori T; Tsunetsugu-Yokota Y
Microbiol Immunol; 1998; 42(4):305-11. PubMed ID: 9623918
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of plasma and salivary antibodies in HIV-1 infection.
Wu X; Jackson S
Viral Immunol; 2002; 15(2):325-35. PubMed ID: 12081015
[TBL] [Abstract][Full Text] [Related]
7. Plasma and salivary IgG subclasses in HIV type 1 infection: evidence of both transudation and local synthesis of IgG in parotid saliva.
Wu X; Jackson S
AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1423-31. PubMed ID: 11018862
[TBL] [Abstract][Full Text] [Related]
8. Salivary detection of HIV-1 antibodies using recombinant HIV-1 peptides.
Archibald DW; Hebert CA
Viral Immunol; 1991; 4(1):17-22. PubMed ID: 2064721
[TBL] [Abstract][Full Text] [Related]
9. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
Mestecky J; Jackson S; Moldoveanu Z; Nesbit LR; Kulhavy R; Prince SJ; Sabbaj S; Mulligan MJ; Goepfert PA
AIDS Res Hum Retroviruses; 2004 Sep; 20(9):972-88. PubMed ID: 15585085
[TBL] [Abstract][Full Text] [Related]
10. Plasma and salivary IgA subclasses and IgM in HIV-1-infected individuals.
Wu X; Jackson S
J Clin Immunol; 2002 Mar; 22(2):106-15. PubMed ID: 11998891
[TBL] [Abstract][Full Text] [Related]
11. Rapid and constant detection of HIV antibody response in saliva of HIV-infected patients; selective distribution of anti-HIV activity in the IgG isotype.
Lü XS; Delfraissy JF; Grangeot-Keros L; Rannou MT; Pillot J
Res Virol; 1994; 145(6):369-77. PubMed ID: 7709073
[TBL] [Abstract][Full Text] [Related]
12. Frequent detection of HIV- and IgG-specific IgM and IgA antibodies in HIV-positive cord-blood sera: fine analysis by western blot.
Schüpbach J; Wunderli W; Kind C; Kernen R; Baumgartner A; Tomasik Z
AIDS; 1989 Sep; 3(9):583-9. PubMed ID: 2506903
[TBL] [Abstract][Full Text] [Related]
13. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection.
Cartry O; Moja P; Quesnel A; Pozzetto B; Lucht FR; Genin C
Clin Exp Immunol; 1997 Jul; 109(1):47-53. PubMed ID: 9218823
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects.
Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1365-76. PubMed ID: 10515152
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions.
Haimovici F; Mayer KH; Anderson DJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):185-91. PubMed ID: 9257652
[TBL] [Abstract][Full Text] [Related]
16. Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients.
Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
J Immunol Methods; 1999 Jan; 222(1-2):111-24. PubMed ID: 10022378
[TBL] [Abstract][Full Text] [Related]
17. Opposite immune reactivity of serum IgG and secretory IgA to conformational recombinant proteins mimicking V1/V2 domains of three different HIV type 1 subtypes depending on glycosylation.
Granados-Gonzalez V; Claret J; Berlier W; Vincent N; Urcuqui-Inchima S; Lucht F; Defontaine C; Pinter A; Genin C; Riffard S
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):289-99. PubMed ID: 18260782
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-HIV-1 IgG antibodies in whole saliva by GACELISA and Western blot assays.
Matee MI; Lyamuya EF; Simon E; Mbena EC; Kagoma C; Samaranayake LP; Scheutz F
East Afr Med J; 1996 May; 73(5):292-4. PubMed ID: 8756029
[TBL] [Abstract][Full Text] [Related]
19. IgA antibodies to human immunodeficiency virus in serum, saliva and urine for early diagnosis of immunodeficiency virus infection in Ugandan infants.
Morgado de Moura Machedo JE; Kayita J; Bakaki P; Coulter JB; Ndugwa CM; Tindyebwa D; Hart CA
Pediatr Infect Dis J; 2003 Feb; 22(2):193-5. PubMed ID: 12613456
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
